Estrone-derivatives having cytoprotective activity

C - Chemistry – Metallurgy – 07 – J

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07J 1/00 (2006.01) A61K 31/565 (2006.01) A61K 31/566 (2006.01) A61P 39/00 (2006.01)

Patent

CA 2427817

The present invention is directed to modified, hydroxy-bearing aromatic ring structures having cytoprotective activity. More specifically, in a first embodiment the present invention is directed to phenolic compounds, and in particular steroids (e.g., estrogens), wherein a non-fused polycyclic, hydrophobic substituent is attached to the hydroxy-substituted A-ring thereof. The present invention is further directed to a process for conferring cytoprotection to a population of cells involving the administration of the compounds.

L'invention porte sur des structures de cycles aromatiques à substitution hydroxy et à activité cytoprotectrice, plus spécifiquement sur des composés phénoliques et plus particulièrement des stéroïdes (par exemple des oestrogènes) au cycle A à substitution hydroxy desquelles est fixé un substituant polycyclique hydrophobe non fusionné. L'invention porte en outre sur un procédé conférant la cytoprotection à une population de cellules impliquant l'administration de ces composés.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Estrone-derivatives having cytoprotective activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Estrone-derivatives having cytoprotective activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Estrone-derivatives having cytoprotective activity will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1567654

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.